BioPharmX Corp fka BPMX

[The Law (f/k/a emz)]

Cash and cash equivalents as of January 31, 2018, were $7.6 million. Additionally, BioPharmX reported that after the end of the year and through the date of this press release, the company received $7.0 million in cash through warrant exercises subsequent to January 31, 2018.

If Warrant Holders have faith/exercising, I have faith!